Retrogenix and Resonant Therapeutics Announce Strategic Alliance
Retrogenix and Resonant Therapeutics announce strategic alliance to identify targets of anti-tumor antibodiesRead more →
Resonant Therapeutics Announces Collaboration with Janssen
Resonant Therapeutics announced that the company has entered into an agreement with Janssen Research and Development to discover and validate novel tumor and immunological targets, and to validate certain therapeutic candidates.
Partner with Resonant
Resonant technology can dramatically expand your drug discovery pipeline. Resonant customizes tumor microenvironment models to reflect specific disease states and microenvironment conditions.Find out more